These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 21562595

  • 1. Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle.
    Karvinen H, Pasanen E, Rissanen TT, Korpisalo P, Vähäkangas E, Jazwa A, Giacca M, Ylä-Herttuala S.
    Gene Ther; 2011 Dec; 18(12):1166-72. PubMed ID: 21562595
    [Abstract] [Full Text] [Related]

  • 2. Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer.
    Pajusola K, Künnapuu J, Vuorikoski S, Soronen J, André H, Pereira T, Korpisalo P, Ylä-Herttuala S, Poellinger L, Alitalo K.
    FASEB J; 2005 Aug; 19(10):1365-7. PubMed ID: 15958522
    [Abstract] [Full Text] [Related]

  • 3. Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs.
    Chen F, Tan Z, Dong CY, Chen X, Guo SF.
    Acta Pharmacol Sin; 2007 Apr; 28(4):493-502. PubMed ID: 17376288
    [Abstract] [Full Text] [Related]

  • 4. Combination of VEGF(165)/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization.
    Chen F, Tan Z, Dong CY, Li X, Xie Y, Wu Y, Chen X, Guo S.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):222-30. PubMed ID: 17553485
    [Abstract] [Full Text] [Related]

  • 5. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H, Lu R, Kan YW.
    Proc Natl Acad Sci U S A; 2000 Dec 05; 97(25):13801-6. PubMed ID: 11095751
    [Abstract] [Full Text] [Related]

  • 6. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
    Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Ordén MR, Kholová I, de Goede A, Heikura T, Gröhn OH, Ylä-Herttuala S.
    Circulation; 2005 Dec 20; 112(25):3937-46. PubMed ID: 16344386
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
    Vajanto I, Rissanen TT, Rutanen J, Hiltunen MO, Tuomisto TT, Arve K, Närvänen O, Manninen H, Räsänen H, Hippeläinen M, Alhava E, Ylä-Herttuala S.
    J Gene Med; 2002 Dec 20; 4(4):371-80. PubMed ID: 12124979
    [Abstract] [Full Text] [Related]

  • 8. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
    Byun J, Heard JM, Huh JE, Park SJ, Jung EA, Jeong JO, Gwon HC, Kim DK.
    J Mol Cell Cardiol; 2001 Feb 20; 33(2):295-305. PubMed ID: 11162134
    [Abstract] [Full Text] [Related]

  • 9. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors.
    Zacchigna S, Papa G, Antonini A, Novati F, Moimas S, Carrer A, Arsic N, Zentilin L, Visintini V, Pascone M, Giacca M.
    Am J Pathol; 2005 Oct 20; 167(4):981-91. PubMed ID: 16192634
    [Abstract] [Full Text] [Related]

  • 10. Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression.
    Tafuro S, Ayuso E, Zacchigna S, Zentilin L, Moimas S, Dore F, Giacca M.
    Cardiovasc Res; 2009 Sep 01; 83(4):663-71. PubMed ID: 19443424
    [Abstract] [Full Text] [Related]

  • 11. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
    Kupatt C, Hinkel R, Pfosser A, El-Aouni C, Wuchrer A, Fritz A, Globisch F, Thormann M, Horstkotte J, Lebherz C, Thein E, Banfi A, Boekstegers P.
    J Am Coll Cardiol; 2010 Jul 27; 56(5):414-22. PubMed ID: 20650363
    [Abstract] [Full Text] [Related]

  • 12. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ, Spiga MG, Graham RM, Wilson A, Haliko S, Lieber BB, Wakhloo AK, Webster KA.
    Gene Ther; 2005 May 27; 12(9):762-71. PubMed ID: 15772688
    [Abstract] [Full Text] [Related]

  • 13. Baculovirus-mediated vascular endothelial growth factor-D(ΔNΔC) gene transfer induces angiogenesis in rabbit skeletal muscle.
    Heikura T, Nieminen T, Roschier MM, Karvinen H, Kaikkonen MU, Mähönen AJ, Lesch HP, Rissanen TT, Laitinen OH, Airenne KJ, Ylä-Herttuala S.
    J Gene Med; 2012 Jan 27; 14(1):35-43. PubMed ID: 22162149
    [Abstract] [Full Text] [Related]

  • 14. [The in vivo and in vitro effects on neovascularization of VEGF gene transfer with a new pseudotyped rAAV1 vector].
    Yan H, Wu XB, Guo YH, Zhang P, Chen L, Dong XY, Wang GS, Gao W.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan 27; 35(1):69-73. PubMed ID: 17386170
    [Abstract] [Full Text] [Related]

  • 15. Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors.
    Yan H, Guo Y, Zhang P, Zu L, Dong X, Chen L, Tian J, Fan X, Wang N, Wu X, Gao W.
    Biochem Biophys Res Commun; 2005 Oct 14; 336(1):287-98. PubMed ID: 16129416
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo.
    Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A, Sinagra G, Giacca M.
    Mol Ther; 2004 Nov 14; 10(5):844-54. PubMed ID: 15509502
    [Abstract] [Full Text] [Related]

  • 17. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
    Korpisalo P, Hytönen JP, Laitinen JT, Laidinen S, Parviainen H, Karvinen H, Siponen J, Marjomäki V, Vajanto I, Rissanen TT, Ylä-Herttuala S.
    Eur Heart J; 2011 Jul 14; 32(13):1664-72. PubMed ID: 21138938
    [Abstract] [Full Text] [Related]

  • 18. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW, Hinkel R, Müller S, Delker S, Kreuzpointner R, Kupatt C, Katus HA, Kleinschmidt JA, Boekstegers P, Müller OJ.
    Gene Ther; 2008 Jan 14; 15(1):12-7. PubMed ID: 17943147
    [Abstract] [Full Text] [Related]

  • 19. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholová I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Ylä-Herttuala S.
    Circ Res; 2003 May 30; 92(10):1098-106. PubMed ID: 12714562
    [Abstract] [Full Text] [Related]

  • 20. Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb.
    Chang DS, Su H, Tang GL, Brevetti LS, Sarkar R, Wang R, Kan YW, Messina LM.
    Mol Ther; 2003 Jan 30; 7(1):44-51. PubMed ID: 12573617
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.